Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN104774881B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104774881B enables high-purity L-ABA via enzymatic one-pot synthesis, offering cost and supply chain advantages for pharmaceutical intermediates.